investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Validating Syk as a Target for AML Therapy

Kimberly Stegmaier

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Hao Yuan Kueh

Single cell analysis of hematopoietic cell fate determination

Leukaemia

Dean W Felsher

Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death

Leukaemia

Robert G Roeder

Function and targeting of a stable transcription factor complex in leukemia

Leukaemia

Scott E Evans

Epithelial mechanisms of inducible resistance to AML-associated pneumonia

Leukaemia

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Leukaemia

Julia Kubanek

Ecological Leads for Drug Discovery from Marine Organisms

Leukaemia

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Pathology Hematology and hematologic malignancies

Danilo Perrotti

Role of microRNAs in the Regulation of CML Stem Cell Self Renewal and Survival

Leukaemia

Pathology Hematology and hematologic malignancies

Ross L Levine

Role of TET2 mutations in malignant transformation and acute myeloid leukemia

Leukaemia